ELOX · NASDAQ
Eloxx Pharmaceuticals (ELOX) Stock Price & Fundamentals
Eloxx Pharmaceuticals (ELOX) closed at $448.74 on Oct 9, 2026, up 1.09% from the previous close of $443.92.
Share price, past year
1Y +5.25%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $448.74 |
| Sep 30, 2026 | $451.37 |
| Aug 31, 2026 | $430.47 |
| Jul 31, 2026 | $440.40 |
| Jun 30, 2026 | $452.58 |
| May 29, 2026 | $453.64 |
| Apr 30, 2026 | $441.64 |
| Mar 31, 2026 | $431.70 |
| Feb 27, 2026 | $437.12 |
| Jan 30, 2026 | $462.73 |
| Dec 31, 2025 | $434.27 |
| Nov 28, 2025 | $431.04 |
| Oct 31, 2025 | $421.90 |
Key statistics
- Market cap
- $1.81B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 4M
- Dividend yield
- —
- 52-week range
- $416.96 – $473.02
Eloxx Pharmaceuticals's market cap is $1.81B, based on a share price of $448.74 and 4M shares outstanding as of Jun 30, 2026.
Financials
Eloxx Pharmaceuticals reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Eloxx Pharmaceuticals reported a net loss of $6.00M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | −100.0% | −$6.00M | — | −$0.49 | — |
| FY2024ended Dec 31, 2024 | $6.36M | — | −$3.14M | −49.4% | −$0.84 | — |
| FY2023ended Dec 31, 2023 | $0.00 | −100.0% | −$17.05M | — | −$6.63 | — |
| FY2014ended Jun 30, 2014 | $182.23K | +2,230.6% | — | — | — | −$4.87M |
| FY2013ended Jun 30, 2013 | $7.82K | −96.1% | — | — | — | −$3.90M |
| FY2012ended Jun 30, 2012 | $200.00K | +42.9% | — | — | — | −$4.39M |
| FY2010ended Jun 30, 2010 | $140.00K | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2013ended Dec 31, 2012 | $0.00 | — | — |
| Q2 FY2012ended Dec 31, 2011 | $200.00K | — | — |
Company profile
- Name
- Eloxx Pharmaceuticals, Inc.
- Ticker
- ELOX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- P.O. Box 274, Arlington, MA 02476
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001035354
Recent SEC filings
- Aug 11, 2026
- Aug 11, 2026
- Jun 1, 2026
- May 5, 2026
- May 1, 2026
- Mar 17, 2026
- Aug 12, 2025
- Oct 17, 2024
Frequently asked questions
What is Eloxx Pharmaceuticals's stock price?
Eloxx Pharmaceuticals (ELOX) closed at $448.74 on Oct 9, 2026, up 1.09% from the previous close of $443.92.
What is Eloxx Pharmaceuticals's market cap?
Eloxx Pharmaceuticals's market cap is $1.81B, based on a share price of $448.74 and 4M shares outstanding as of Jun 30, 2026.
How much revenue does Eloxx Pharmaceuticals make?
Eloxx Pharmaceuticals reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Sources and methodology
Fundamentals come from Eloxx Pharmaceuticals, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures